ARX vs CGS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

CGS

COGSTATE FPO [CGS]

58MEDIUM

Score Breakdown

ARX CGS
Technical
38
47
Catalyst
50
53
Sentiment
50
50
Fundamental
95
96
Momentum
55
79
Risk Gate
50
50

Key Metrics

ARX Metric CGS
$202.9MMarket Cap$489.3M
314KAvg Volume (20d)397K
N/AShort Interest+0.1%
$0.80052-Week High$3.010
$0.49552-Week Low$1.550
-0.8%Daily Change-3.5%
$0.580Reference Price$2.780
+4.9%ROE+22.5%
+4.5%Profit Margin+19.2%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.6x) on a red day — sellers in control
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.0x)

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ARX and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs MVP →CGS vs EYE →CGS vs MVP →AHC vs CMP →AHC vs ARX →
ARX Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).